At Zebx, we focus on introducing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening chronic diseases. Zebx remains steadfast to its original mission—to bring new treatments to market that will make a big impact on patient populations.

These patient populations are mostly in middle adulthood, suffering from diseases so common, that the entire patient population can number as large as millions people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options, and are usually ignored.

Time is critical to patients with chronic pain and diseases, and we strive to quickly provide important therapies for them. The efficiency and speed of our system, and commercial efforts is at the heart of our ability to urgently deliver therapies. As a biopharmaceutical company, our success stems from our focus on science and the hope our therapies can bring to patients.

We are started of with a mission to become world leaders in metabolic disease innovation with multiple products commercialized and a growing pipeline of product candidates to address unmet medical needs. We continue to fuel our R&D engine by looking for opportunities that align with our strengths and competencies. And we relentlessly pursue exciting, early-stage science that has the potential to change the course of disease.